RE:Bioasis ConnectionsI see so many things at Bioasis to leverage into valuable initiatives. I understand how much hope there is in that. But when I see a lousy press release like the Cresence PR, that didn't anticipate for a moment that it could mean to shareholders that xB3 is being back-shelved, or lowered in importance, which it's not, then I wonder whether there is a thought of any kind being given to anticipating shareholder reactions to anything.
That PR should have mentioned that the new technology is a small molecule (a peptide????), that a P2 clinical trial will likely have very few participants, resulting in relatively low costs, but most importantly, that the acquired technology will be advanced in concert with Bioasis's flagship technology, the xB3 Platform.
Never should that PR have allowed any consideration of xB3 weakness. There should have been full confidence expressed about xB3 and that the company will continue to advance xB3 in a vigorous manner.
And saying something like, oh well, investors didn't read it correctly is self-deception. IT IS UP TO THE PR's AUTHORS TO PROPERLY PROJECT THE INTERESTS AND CAPABILITIES OF ITS TECHNOLOGIES AND PROSPECTS.
And the takes that the roadshows and webcasts presented on a move to Nasdaq were certainly less than inspiring. They caused worry about rollbacks and dilution while keeping some important information secret, except for those who accidently saw it.
Amateur stuff. Hubris unbridled.
I support the real things that the company is doing but the news, coupled with projections about Nasdaq, were so poor that the stock actually hit 16¢, enough proof that the presentation, IR and promotion were far from adequate. I don't think it could actually be planned in a manner that could have produced such poor results.
It's time for this operation to buck up and set a tone and image about Bioasis and xB3 that is positive, confident and BIG. And if you can't do it, get some IR who can do it.
And no, the corporate presentation, as I write this, has still not been updated. No mention of Cresence, clinical-stage and the new programs.
I have to ask the question, if the corporate presentation was updated with the new information, would Bioasis also have to update some other stuff in the presentation that is now outdated and the company doesn't want to reveal it yet? Is that why it's not been updated? Is Bioasis hiding behind apparent procrastination?
But I am generally positive about what could be done. My "Connections" post is positive, and you will learn why some day soon, but there is so much more that can be done.
Yell it from the rooftops, or find somebody with the voice for it!
jd